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Chromatin programming by developmentally regulated 
transcription factors: lessons from studying hematopoietic 
specification and differentiation 
 
Nadine Obier and Constanze Bonifer 
Institute of Cancer and Genomic Sciences, College of Medicine and Dentistry, 
University of Birmingham, UK 
 
Abstract:  
While the body plan of individuals is encoded in their genomes, each cell type 
expresses a different gene expression program and thus accesses only a subset of 
this information. Alterations to gene expression programs are the underlying basis 
for the differentiation of multiple cell types and are driven by tissue-specific 
transcription factors (TFs) which interact with the epigenetic regulatory machinery to 
program the chromatin landscape into transcriptionally active and inactive states. 
The hematopoietic system has long served as a paradigm to study the underlying 
molecular principles of developmental specific gene expression control. In this 
review, we will summarize what is known about the mechanism of action of TFs 
regulating hematopoietic specification and differentiation and we will place this 
knowledge into the context of general principles of the control of development. 
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General principles of the developmental control of gene expression  
The control of development involves the successive activation and silencing of 
specific gene expression programs and thus the selective and cell-type specific use 
of the transcription machinery which needs to negotiate a chromatin template. 
Chromatin architecture is an important component of transcription regulation 
because in the absence of nucleosomes the normal dynamic range of transcription is 
lost [1]. However, compact chromatin also presents a formidable barrier to the 
transcription apparatus and requires the concerted action of multiple transcription 
factors to overcome it [2, 3]. Therefore activation of eukaryotic genes requires an 
opening up of chromatin structure along an entire genomic domain [4]. There are 
several ways of performing such a task. One is the passage of a RNA-polymerase 
complex and its associated factors that splits the two DNA strands as well as 
dislodges nucleosomes [5, 6]. The other way is via the formation of stable 
transcription factor (TF) complexes at specific sequences within an active gene 
domain which interact with each other in 3D space and form an active chromatin hub 
[7]. Such complexes consist of TFs recognizing specific DNA sequences which, in 
turn, recruit non-DNA binding co-factors such as chromatin remodellers and 
modifiers to initiate and maintain an active chromatin state (Figure 1). To 
understand, how genes are activated and silenced thus driving transitions between 
cell types during development, regeneration and homeostasis in development, we 
need to highlight a number of important concepts.  
Firstly, an active chromatin structure needs to be constantly maintained. It is 
now abundantly clear that each transcription cycle is regulated by the balance of 
activating and repressing factors which ensure that gene expression does not 
overshoot [8]. In the absence of activators, repressing factors, such as DNA-
methyltransferase and histone deacetylases take over, and establish an inactive 
chromatin structure which is characterised by the absence of TF binding, methylated 
DNA and deacetylated histones. The second important principle is that an inactive 
chromatin state is self-perpetuating [9]. This is assured by the deposition of inactive 
histone marks such as histone H3 lysine 9 methylation (H3K9me3) or H3K27 
trimethylation (H3K27me3) which bind silencing factors such as heterochromatin 
protein 1 (HP1) or Polycomb complexes, which, in turn recruit more co-repressors. 
Moreover, methylated DNA binds methyl-binding proteins that interact with co-
repressors as well. Since DNA methylation is faithfully copied during cell division [10] 
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repressive complexes are restored and an inactive chromatin structure reforms at 
inactive genes.  
Inactive chromatin is compact, but at the same time highly dynamic. FRAP 
(fluorescence recovery after photo-bleaching) data employing GFP-tagged histone 
and chromatin components showed that while nucleosomes tend to bind with a long 
half-life, transcription factors and non-histone proteins whizz in and out of chromatin 
complexes within seconds [11, 12] thus presenting windows of opportunities where 
transcription factors can slip in. Single-molecule imaging studies showed that 
different  TFs patrol the genome and only briefly interact with DNA, but get locked 
into stable binding once a specific sequence is available for binding [13].  However, 
there are still open questions as to whether all TFs behave this way and whether all 
states of closed chromatin permit such highly dynamic scanning movements (such 
as Polycomb-associated chromatin, as discussed below [14]). Once binding has 
happened, TFs recruit co-activators, alter chromatin structure from an inactive to an 
active state, which, in the presence of activators is also maintained through mitosis 
as some factors can be mitotically retained at their binding sites [15]. In addition, 
tissue-specific transcription factors cooperate with remodellers to complete with 
nucleosomes post replication and re-establish nucleosome-free regions [16]. 
Transcription factors also compete with the DNA-methylation machinery eventually 
leading to demethylation, either by a passive mechanism or by the active recruitment 
of demethylase complexes such as TET2 [17, 18]. Depending on which 
transcriptional regulators are expressed, gene expression patterns are either 
inherited, thus fulfilling the original definition of epigenetics, or change, driving 
differentiation. Here we will concentrate on the question of how the chromatin 
landscape presents itself to transcription factors in a developmental context.  
 
Regulation of the chromatin landscape in development 
Many textbooks and PhD theses, which describe gene regulation, tend to start with 
the statement that we find two types of chromatin in the eukaryotic nucleus: “open” 
euchromatin and “compact” heterochromatin, containing active and inactive genes, 
respectively. However, whilst this distinction is convenient, is comes nowhere near 
the true complexity of dynamic chromatin structure. For example, it is now clear that 
chromosomes are subdivided into topologically associated domains (TADs) which 
form the structural backbone of chromatin folding and which are able to partition 
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chromosomes into regulatory units [19, 20]. In addition, genomic regions associated 
with the nuclear lamina, so called lamina-associated domains (LADs), are known to 
represent repressive domains and for some examples it was shown that during 
development genes move into LADs when being repressed and move out of LADs 
when being activated [21, 22]. How this intranuclear architecture relates to TADs, 
however, is poorly understood so far. Moreover, chromatin modifications can be 
indicative of many different types of transcriptional states [23]. It is outside of the 
scope of this review to describe the myriad of chromatin proteins and histone 
modifications that regulate chromatin packaging which are the subject of recent 
reviews (such as [24]). However, in the context of this article it is relevant that 
activation and silencing of genes at the level of chromatin structure are gradual 
processes whereas the regulation of mRNA synthesis tends to be rapid and dynamic 
[25]. Alterations in transcription factor occupancy and chromatin structure and 
modifications in development involve the step-wise opening up of chromatin by the 
sequential assembly of factors in the absence of high-level transcription, a process 
that is called priming [25, 26]. Conversely, the inactivation of chromatin also occurs 
gradually, together with the alteration of the transcriptional network within the cell 
[27]. Transcription can be rapidly switched off which can leave genes in a transitory 
or poised state ready for further activation of repression, in response to outside 
signals. This poised state is mediated by Polycomb repressive complexes (PRC) 
consisting of many different subunits, but involving two types of complexes: PRC1 
and PRC2. PRC2 contains a histone modification enzyme (EZH1/2) that deposits 
one, two or three methyl groups on histone H3K27. The H3K27me3 mark comprises 
a binding site for PRC1 which then ubiquitinates histone H2A. The result of the 
formation of Polycomb complexes on promoters and the alteration of chromatin 
modification is a block of transcriptional elongation by RNA-Polymerase II. However, 
the non-elongating form of RNA-Polymerase is still binding to Polycomb-repressed 
promoters [28]. In contrast to the classical consecutive Polycomb-repression model 
where PRC1 follows PRC2, recent publications also describe a non-canonical class 
of PRC1 which acts independently of H3K27me3 and where PRC1-mediated 
H2AK119 ubiquitination recruits PRC2 [29-33].  
 How does this translate into chromatin architecture? A recent elegant study 
used FISH combined with super-resolution imaging (STORM) to ask the question of 
the actual level of compaction of actively transcribed, inactive as defined by a lack of 
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transcription factor binding and histone modification, and Polycomb-associated 
poised chromatin within the Drosophila nucleus [14]. The choice and classification of 
gene domains was based on published high-throughput gene expression and 
chromatin modification data. Bona-fide heterochromatic regions which represent 
permanently silenced genomic regions [3] such as telomeres or centromers were not 
analysed. Each of the three classes of chromatin domain had a different level of 
compaction, with, as expected, transcriptionally active chromatin carrying a high 
level of histone acetylation having the lowest level of compaction. A surprising result 
was that transcriptionally inactive and active regions strongly intermingle. In addition, 
Polycomb-associated chromatin showed the highest level of chromatin compaction 
which was dependent on the presence of Polycomb as shown by knock-down 
experiments, and displayed the least intermingling with other types of domains. 
Polycomb-associated domains showed a very high level of intermixing within their 
domains and behaved like sticky polymers, in line with other experiments in mouse 
ES cells demonstrating that PRC1 complexes are responsible for promoter-promoter 
contacts [34]. However, whether Polycomb-bound chromatin always has the highest 
level of compaction also in mammals is less clear [35]. It is also unclear, how histone 
modifications, other non-histone proteins and, in vertebrates, DNA-methylation 
contribute to the compaction status. In any case, these findings highlight the notion 
that actual chromatin folding is independent from the activity status of the 
transcription unit. Instead, chromatin architecture is under developmental control 
determining whether genes are going to be active, have been active or going to be 
inactive and thus present different targets for transcription factors to negotiate in 
different cell types.  
In the next chapter we will describe hematopoiesis as a model to highlight examples 
for these principles. 
  
The hematopoietic system as a model to study the developmental control of 
chromatin programming and gene expression 
During embryonic development blood cells emerge from the mesodermal germ layer 
and their formation occurs temporally and spatially distinctly: the first wave of mouse 
hematopoiesis takes place in the extra-embryonic blood islands of the yolk sac 
around day E8.5 and gives rise to primitive progenitor cells with limited potential, 
mostly erythroid and myeloid [36, 37]. In contrast, the second wave takes place at 
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day E10.5 at the ventral part of the dorsal aorta in the aorta-gonad-mesonephros 
(AGM) region of the embryo [38]. Cells emerging during the second wave of 
hematopoiesis are definitive hematopoietic stem cells (HSCs) that migrate first to the 
fetal liver and later to the bone marrow where they undergo self-renewal and 
differentiation throughout lifetime to sustain mature blood cell production. It is 
believed that a common precursor for hematopoietic and endothelial cells exists, the 
hemangioblast, which differentiates to a specialised endothelium in the dorsal aorta, 
the hemogenic endothelium (HE). Cells of the HE undergo an endothelial-to-
hematopoietic transition (EHT), during which they detach from the endothelial layer 
and give rise to intra-aortic clusters of cells comprising HSCs which are then 
transported to the fetal liver by blood circulation [39-41]. The in vitro differentiation of 
embryonic stem (ES) cells can be used to recapitulate these developmental 
transitions and proved to be a powerful tool in order to gain access to rare transient 
cell populations for studying molecular mechanisms of development [42, 43] (Figure 
2A). To this end, pluripotent ES cells are differentiated as embryoid bodies (EBs) 
and hemangioblast cells are purified based on surface expression of FLK1, i.e. 
VEGF receptor. Hemangioblast cells can be further differentiated in the presence of 
BMP4, Activin A and VEGF to smooth muscle, endothelial and hemogenic 
endothelial cells [39, 44, 45]. Like in the developing embryo, in vitro HE cells 
undergo an EHT and form hematopoietic progenitor cells which is accompanied by a 
downregulation of the endothelial program and an upregulation of the hematopoietic 
program. These developmental pathways are highly conserved in vertebrates and 
research from a variety of model organisms, including zebrafish and xenopus, 
contributed to the knowledge we have today [46-48]. Further, immortal hematopoietic 
precursor cell (HPC) lines have been established from differentiated mouse ES cells, 
such as the HPC7 line [49].         
Using such in vitro models of hematopoietic development helped elucidating 
the role of developmental stage-specific TFs and subsequent changes of the 
chromatin landscape [50]. For example, by using knockout ES cell lines it was shown 
that in the absence of the TF SCL/TAL1 differentiation of hemangioblast to HE cells 
was blocked, thus highlighting the requirement of SCL/TAL1 for this transition [39, 
51]. Further, RUNX1 was found to be essential for the EHT where it activates the 
hematopoietic program [39, 52], but also a role of RUNX1 was described in HE cells 
prior to the EHT where it positively regulates cell adhesion genes [53]. GFI1 proteins 
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were identified as transcriptional repressors needed for silencing of endothelial 
genes during the EHT [54, 55], while SOX17 proteins were shown to repress 
hematopoietic genes to maintain the endothelial fate in HE cells [56]. Moreover, 
several groups mapped open chromatin, histone modifications and TF binding in a 
genome-wide fashion, revealing common and distinct target genes within highly 
dynamic transcriptional networks that regulate developmental transitions [42, 57].   
 
Chromatin activation and silencing during hematopoiesis occur in stages   
A large number of single gene studies have given us a first insight into how 
transcription factors assemble during hematopoietic differentiation from lineage-
committed progenitors. As already alluded above, also here it was obvious that the 
activation of individual genes at the level of chromatin remodelling starts way ahead 
of its high level transcriptional activation.  A good example for this notion is the Csf1r 
locus which encodes the receptor for colony-stimulating-factor 1 (CSF1-R), an 
essential growth factor for macrophage development ([58]). This gene is expressed 
at a very low level in early hematopoietic progenitor cells, but is strongly up-
regulated in committed macrophage precursors. However, even at an early 
differentiation stage, the gene is occupied by transcription factors and its chromatin 
is already reorganized and unmethylated. In fact, a number of studies have shown 
that demethylation of DNA predicts enhancer activity later in development ([59-61]. 
The up-regulation of the expression of this gene during macrophage differentiation 
and its response to stimuli is accompanied by the dynamic assembly of different 
transcription factors [62, 63]. Conversely, the silencing of this gene during B-
lymphopoiesis is a gradual process as well, whereby mRNA synthesis ceases first, 
caused by the silencing of the promoter by the B-cell commitment factor PAX5, 
followed by a gradual inactivation of chromatin and increased DNA methylation ([64]. 
Such general behaviour of activation and repression of cis-regulatory elements in 
alternate lineages, with some lineage-specific variation, has now been multiple times 
been shown to be true at the genome-wide level (for examples see [42, 65-67].  
Development occurs via a series of lineage choices whereby daughter cells 
eventually start to diversify and switch specific genes on from the silent state.  As 
outlined above, the silent state comes in different flavours and involves various types 
of chromatin (inactive, repressed, permanently silenced (hetero-)chromatin). How do 
different types of transcription factors recognise DNA in these different states? This 
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question is not only important if we want to understand normal development, but also 
in the context of reprogramming the epigenetic landscape towards pluripotency from 
somatic cells. As it turns out, life uses multiple mechanisms to solve the problem that 
most transcription factors have trouble reading the DNA sequence when it is covered 
by a nucleosome. One mechanism involves a class of transcription factors capable 
of binding to nucleosomes which mark inactive chromatin for successive activation 
and successive factor assembly, so called “pioneer factors” the most prominent of 
which is the winged-helix factor FOXA2 [68, 69]. However, other pioneer factor 
types, such as EBF1 have also been found [70]. In addition, TFs can recognise 
partial binding sequences and cooperate to destabilize nucleosomes, followed by the 
recruitment of histone remodelers and modifiers once a stable complex has formed 
[71].   It also has been found that the presence of TFs per se leads to a gradual 
increase in DnaseI accessibility at their cognate binding elements via transient 
binding without forming a stable factor complex. This only forms once all factors 
participating in such a complex are present [72]. Once such a stable complex is 
formed, it recruits chromatin remodellers and modifiers that, in the presence of a 
sufficiently high concentration of participating transcription factors maintain gene 
expression activity (Figure 1). Recent studies described another hit-and-run 
mechanism of interactions between transcription factors and chromatin (assisted 
loading) whereby one type of factor transiently binds to an accessible region in 
chromatin, recruits chromatin remodellers and leaves in favour of another factor 
which binds to the same region [73]. In summary, these different studies show 
clearly that transcription factors cooperate in a highly dynamic and flexible fashion to 
negotiate chromatin. It is therefore likely that these negotiations will be subtly 
different for each gene. We still have only a rudimentary understanding of how the 
cooperation between transcription factors and the epigenetic regulatory machinery 
ensures that genes are expressed at the right time and the right level [74]. 
 
Hematopoietic specification and differentiation is regulated by a relay of 
transcription factors 
The recent years have seen a flurry of genome-wide studies of chromatin alterations 
during adult hematopoiesis as well as TF binding studies within specific 
differentiation steps of the hematopoietic hierarchy. A number of studies used ES 
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cell differentiation to gain insights into the question of how transcription factors 
regulate embryonic hematopoietic specification [42, 67, 75-78].  
The most comprehensive of these studies by Goode et al. [42] mapped both 
global transcription factor binding and the effects of this binding on chromatin 
structure and modification over six consecutive stages of hematopoietic specification 
and differentiation up to the terminally differentiated macrophage stage. The study 
shows that developmental stage-specific TFs successively become activated and 
often enhance their own expression as well as the expression of stage-specific 
genes. In many cases TFs bind to distal regulatory elements of genes before these 
genes are expressed, a phenomenon called “priming”, whereby in the next 
differentiation stage these genes acquire promoter histone modifications associated 
with activation, such as H3K4me3 or H3K9ac, and transcription is initiated. A good 
example for the gradual process of gene activation during development is the gene 
encoding the transcriptional repressor GFI1B which is needed during EHT to down-
regulate the endothelial program [54, 55]. Gfi1b is not expressed in mesodermal or 
hemangioblast cells and is expressed at low levels in HE cells. Transcription is 
highest in HP cells but is then down-regulated and no longer expressed in 
macrophages. Although the gene is not expressed at the hemangioblast stage, 
hematopoietic TFs such as SCL, GATA2 and LMO2 bind to Gfi1b regulatory regions, 
while the promoter is still marked by the repressive Polycomb modification 
H3K27me3 (Figure 2). Subsequently, in HE and HP cells H3K27 methylation is 
absent, the promoter is marked by H3K4me3 and distal elements are cooperatively 
bound by a combination of TFs such as GATA1, GATA2, FLI1, ERG, LMO2, RUNX1 
and SCL. In macrophages these factors no longer bind to Gfi1b, the promoter re-
gains H3K27me3 and transcription is abrogated. This example demonstrates how 
tissue-specific TFs in a combinatorial fashion program the chromatin template in 
order to control gene expression at specific developmental stages. However, there is 
more and more evidence that it is not only tissue-specific TFs alone that perform 
these programming events, but in many developmental contexts ubiquitously 
expressed and signalling-inducible TFs cooperate with them. For example, from 
motif analyses of DNA sequences within DNaseI hypersensitive, i.e. chromatin sites 
which are accessible due to TF binding it could be shown that the Hippo-signalling-
sensitive TF TEAD4 binds to sites occupied by tissue-specific TFs such as FLI1 and 
SCL/TAL1 during early hematopoietic specification and that binding and the 
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interaction with its co-factor YAP is essential for the generation of hematopoietic 
cells in vitro [42]. Further, in the absence of the ubiquitous TF SP1 during early 
embryonic hematopoiesis, later stages of differentiation are severely affected, 
highlighting the role of such factors for tissue-specific gene regulation and chromatin 
programming [76].   
While some TFs are known for their potential to activate gene expression, 
others have repressive potential during hematopoietic specification. Examples are 
GFI1/GFI1B proteins which repress the endothelial program during the EHT [54, 55], 
or SOX17 which represses hematopoietic genes in HE cells [56]. However, it 
remains a challenge for researchers to understand how exactly some TFs at defined 
genomic elements, in combination with specific other factors, at distinct 
developmental stages can act either as activators or repressors. The induction of 
RUNX1 during the EHT results in a vast number of genes being bound by RUNX1, 
and while most of them are transcriptionally activated, some others are down-
regulated, e.g. Sox17 [75]. Also SCL/TAL1, PAX5 and EBF1 were shown to have a 
context-dependent activating or repressive effect on gene expression [79-82]. It is 
therefore likely that the nature of TF assemblies determines a context-dependent 
recruitment of activating or repressive members of the epigenetic regulatory 
machinery.  
 
The epigenetic regulatory machinery modifying transcription factors and 
chromatin components is essential for hematopoietic development 
A variety of regulatory mechanisms can be used by a cell to regulate TF activities 
such as modulating transcription of the TF gene itself, post-translational 
modifications that allow or prevent nuclear localisation, and post-translational 
modifications that affect the protein stability and activity. Second, TFs often act 
together with other TFs and for some genes spatial and temporal co-expression of a 
set of co-operative TFs and their co-binding is a prerequisite for transcriptional 
initiation. Third, TFs recruit enzymatic co-factors which remodel and modify the 
chromatin template, make it more accessible and in case of promoter-enhancer 
looping support the assembly and initiation of the transcriptional machinery at the 
target promoters.  
An example of a TF that can be subject to modifications itself and that recruits 
chromatin modifiers is RUNX1. Depending on cell type and genomic region, RUNX1 
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was reported to interact with a multitude of different modifiers such as histone 
acetyltransferases [83, 84] and the nucleosome remodeller SWI/SNF [85] that 
support the activating role of RUNX1. However, RUNX1 can also recruit repressive 
complexes like Suv39H1 [86], mSin3A [87] or Polycomb group proteins [88] as well 
as histone deacetylases [89] reflecting that it can also act as a repressor of 
transcription. Further, it has been shown that MAPK signalling via ERK can causes 
phosphorylation of the RUNX1 protein which subsequently leads to the 
disaggregation of a complex that RUNX1 can form with the repressor mSin3A, thus 
removing repressive potential from the TF and enhancing its activating roles [87]. 
Moreover, the histone acetyltransferases p300/CBP and MOZ can have a dual role 
when forming a complex with RUNX1: i) recruited by RUNX1 these enzymes boost 
histone acetylation of the nearby nucleosomes, help opening up the chromatin fibre 
and provide a binding platform for other activators containing bromodomains, ii) 
p300/CBP and MOZ can use RUNX1 itself as their substrate and thus increase its 
transactivation potential [83, 84]. In the light of this complexity it is not surprising that 
mutations, deletions or translocations affecting chromatin modifiers can lead to 
disturbed differentiation and cancer [90].  However, the molecular mechanisms of 
how such mutations derail normal differentiation are still largely unknown and a 
matter of extensive current research. 
 
Conclusions and Perspectives 
The interaction of transcription factors with the chromatin landscape comprises a 
robust, but also highly flexible and dynamic system geared towards a regulated 
response to outside signals and developmental cues. Intermolecular interactions are 
at the heart of these processes and these interactions are specific for each gene. We 
are slowly approaching the point at which we can begin to construct transcriptional 
networks allowing predictions of the transcriptional response of individual cell types 
to changing TF expression levels [91]. However, the integration of the chromatin 
landscape as a dynamic modulator of the transcriptional response of differentiating 
cells into such models presents a formidable problem whose solution is still in its 
infancy. 
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Figure 1: The interaction of transcription factors with chromatin  
(A) Simplified scheme how different ways how transcription factors negotiate the 
chromatin landscape. Transcription factor binding motifs which are placed at different 
position relative to nucleosomes are depicted as coloured rectangles. TF: 
transcription factors which have different properties depending on whether they can 
bind to nucleosomal DNA or not. H1: histone H1 (B) Once a stable transcription 
factor complex has formed, SWI/SNF-type complexes evict nucleosomes and 
facilitate TF binding and co-activator (histone modifier) recruitment. Ac: Histone 
acetylation 
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Figure 2: The developmental activation and deactivation of the Gfi1b locus 
(A) Scheme depicting the differentiation of hemangioblasts, hematopoietic 
progenitors and macrophages from differentiated mouse embryonic stem cells. (B) 
Assembly of transcription factors and histone modifications at the Gfi1b locus 
(modified from Goode et al; 2016) 
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